Philips: adjusted EBITA margin up in Q2

(CercleFinance.com) - Philips reports a one-point improvement in its Q2 2024 adjusted EBITA margin to 11.
1%, although negative free cash flow of E64m, due to payments relating to the settlement of the Respironics litigation in the US.

At E4.5bn, sales of the Dutch medical technology group were up 2% on a comparable basis, with a decline in China offset by strength in other markets, while its order intake was up 9% on a comparable basis.

While acknowledging that uncertainties remain, Philips remains confident in its 2025 plan and confirms its 2024 targets of 3%-5% comparable sales growth, an adjusted EBITA margin of 11%-11.5% and free cash flow of E0.9bn-E1.1bn.


Copyright (c) 2024 CercleFinance.com. All rights reserved.